Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

SHE:000739 Revenue

Apeloa Pharmaceutical Co.,Ltd had revenue of 2.01B CNY in the quarter ending September 30, 2026, a decrease of -13.28%. This brings the company's total for the last twelve months to 8.85B, down -15.64% year-over-year. In the year 2025, Apeloa Pharmaceutical Co.,Ltd had annual revenue of 9.78B, down -18.62%. That makes Apeloa Pharmaceutical Co.,Ltd the 6,443rd largest company in the world by revenue and 897th in China.

• Revenue (ttm): 8.85B
• Revenue Growth: -15.64%
• P/S Ratio: 2.46
• Revenue / Employee: 1.30M
• Employees: 6,787
• Market Cap: 21.77B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceuticals 9.73B 99.4%
• Unallocated Other Operations 55.48M 0.6%

By Geography

Chart

• China 5.45B 55.7%
• Overseas 4.34B 44.3%

Fiscal year ended Dec 31, 2025 See the full SHE:000739 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.78B	-2.24B	-18.62%
Dec 31, 2024	12.02B	547.70M	4.77%
Dec 31, 2023	11.47B	929.26M	8.81%
Jan 1, 2023	10.54B	1.60B	17.92%
Jan 1, 2022	8.94B	1.06B	13.49%

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error